driven by the PitchBook Platform
Developer of therapeutic molecules and theranostic markers. The company eases the treatment of cancer and neurodegenerative diseases through its developed molecules.
You’re viewing a free company profile from the PitchBook Platform. To explore Affichem’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.